❌ Unlike global #IMPower150 (which showed significant PFS/OS benefits), #IMPower151 highlights differences in Asian vs. Western populations: 53% had #EGFR mutations (vs. 14% in IMP150) and 97% used pemetrexed (vs. paclitaxel in IMP150).
#Onco404 #Cancer #Kanser #MedSky #OncSky
❌ Unlike global #IMPower150 (which showed significant PFS/OS benefits), #IMPower151 highlights differences in Asian vs. Western populations: 53% had #EGFR mutations (vs. 14% in IMP150) and 97% used pemetrexed (vs. paclitaxel in IMP150).
#Onco404 #Cancer #Kanser #MedSky #OncSky
Is chemo-Osi likely better than sequencing Osi-IMPOWER 150?
Lung cancer keeps getting more complex!
Is chemo-Osi likely better than sequencing Osi-IMPOWER 150?
Lung cancer keeps getting more complex!